Article Text
Abstract
Objectives Well conducted randomised controlled trials (RCTs) generate the most trustworthy evidence when newly developed or already existing clinical interventions are evaluated. However, RCTs require substantial resources and the costs seem to be increasing over time. As a result, the number of independent investigator-initiated RCTs decreased and a considerable proportion of RCTs are prematurely discontinued due to recruitment delays. Especially in academic research, it is common that clinical studies are underfinanced or that the compensations paid by funders or industries do not cover the actual costs. Therefore, tools for investigators to plan their budgets accurately are essential for the successful conduct of an RCT. In this scoping review we aimed to give an overview of the publicly available budget planning tools.
Method We systematically searched Medline, EMBASE (both via Ovid) and EconLit from inception until May 2018. Additionally, two reviewers conducted an internet search between June and October 2018. We included any tools or cost templates and categorised them if they were primarily intended to (i) plan a budget for an entire RCT, (ii) plan a budget for a separate centre participating in a RCT, or (iii) monitor costs during the conduct of an RCT. From all tools we assessed if they considered direct costs (fixed costs and variable costs) as well as indirect costs, and if they were user tested or validated in any form.
Results We identified 25 tools which were included (i.e. two from the literature search and 23 from the internet search). Of those, 22 tools consisted of programmed Microsoft excel sheets. Seven tools were developed to plan the budget for an entire RCT, 17 tools helped to calculate budgets for a separate study centre participating in an RCT, and the purpose of one tool was to monitor ongoing costs of RCTs. Direct costs, consisting of fixed costs and variable costs were considered by 25 and 21 tools, respectively. Indirect costs were considered by 19 tools. Overall, 18 tools considered all three of these cost aspects. Of the seven tools which can be used to plan costs of an entire RCT, only two included all three relevant cost aspects. Overall, we identified a description of user testing or validation for two tools only.
Conclusions A variety of freely accessible budget planning tools for RCTs exist. Most of the tools were developed internally by different institutions and were not published in a scientific journal. Often it remained unclear if they underwent any form of validation or if they can also be applied in a useful way by researchers who are not part of the institution which developed the tool. We did not find any evidence during this project that a single tool was broadly applied for planning RCT budgets. The fact that many different organisations put effort in developing a budgeting tool shows that the need for accurate planning of RCT budgets was recognised at many levels. Identifying or creating a user-friendly tool which can be used flexibly for different RCTs in different settings should therefore be a research priority.